Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) plasma levels in severe reeclampsia

被引：0
|
作者：
Godoi, L. C. [1 ]
Alpoim, P. N. [1 ]
Madeira, H. [2 ]
Petterson, J. [3 ]
Fernandes, A. P. [1 ]
Carvalho, M. G. [1 ]
Gomes, K. B. [1 ]
Dusse, L. M. S. [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil
[2] Maternidade Odete Valadares Belo Horizonte, Belo Horizonte, MG, Brazil
[3] Hosp Publ Reg Betim, Betim, MG, Brazil
来源：
THROMBOSIS RESEARCH | 2011年 / 127卷
关键词：
D O I：
10.1016/S0049-3848(11)70111-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [21] Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas
    Turker, Meral
    Irken, Gulersu
    Oren, Hale
    Yilmaz, Sebnem
    Yuksel, Faize
    Olgun, Nur
    PEDIATRIC BLOOD & CANCER, 2006, 47 (07) : 914 - 917
  • [22] Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels
    Agledahl, Ingvild
    Brodin, Ellen
    Svartberg, Johan
    Hansen, John-Bjarne
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 471 - 477
  • [23] Measurement of plasma and platelet tissue factor pathway inhibitor (TFPI) in blood donors
    Ellery, P.
    Augustsson, C.
    Maroney, S.
    Wood, J.
    Peterson, L.
    Hilden, I
    Mast, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 61 - 61
  • [24] Heterogenous expression of TF (tissue factor) and tissue factor pathway inhibitors (TFPI, TFPI-2) in loco in different tumors.
    Sierko, E
    Zimnoch, L
    Kisiel, W
    Wojtukiewicz, M
    BLOOD, 2003, 102 (11) : 794A - 794A
  • [25] Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism
    Kwon, Aerin
    Jo, Sang-Ho
    Jo, Yun-A
    Park, Ji-Young
    Kim, Miyoung
    Kang, Hee Jung
    Kim, Han-Sung
    Cho, Hyoun Chan
    Lee, Young Kyung
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (05) : 416 - 421
  • [26] Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
    Shimura, M
    Wada, H
    Wakita, Y
    Nakase, T
    Hiyoyama, K
    Nagaya, S
    Mori, Y
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (04) : 169 - 174
  • [27] PLASMA TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
    SHIMURA, M
    WADA, H
    WAKITA, Y
    NAKASE, T
    HIYOYAMA, K
    NAGAYA, S
    SHIKU, H
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1435 - 1435
  • [28] Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
    Shimura, M
    Wada, H
    Wakita, Y
    Nakase, T
    Hiyoyama, K
    Nagaya, S
    Mori, Y
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 52 (03) : 165 - 170
  • [29] Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: Effect on TFPI activity
    Li, A
    Wun, TC
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 423 - 427
  • [30] LEVELS OF MESSENGER-RNA CODING FOR TISSUE-FACTOR (TF) AND TISSUE-FACTOR COAGULATION INHIBITOR (TFPI) IN RESTING AND STIMULATED MONOCYTES
    FOSTER, S
    MCGEE, MP
    FASEB JOURNAL, 1993, 7 (03): : A116 - A116
12345